Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
NYSE Content advisory: Pre-Market update + Trump announces 50% levy on copper imports 2025-07-09 20:55
GenScript Biotech Earns EcoVadis Silver Medal, Ranking in Top 15% Globally for Sustainability 2025-07-09 20:32
IASO Bio Receives Orphan Drug Designation from the Ministry of Food and Drug Safety of South Korea for Equecabtagene Autoleucel 2025-07-09 20:18
Gozellix Receives Permanent HCPCS Code 2025-07-09 12:41
Watson-Marlow Fluid Technology Solutions focuses on BioClamp's sustainability benefits and new WMArchitect Interchangeable Parts service at INTERPHEX Tokyo 2025 2025-07-09 11:30
First Patient Dosed in Phase 1/2 Clinical Study of Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418 2025-07-09 11:14
GLOBAL NUTRACEUTICALS CAMPAIGN TO RAISE FUNDS FOR RESCUE SHELTER FOR CHILD SEXUAL ABUSE SURVIVORS 2025-07-08 20:00
WuXi AppTec Provides Updates on Q2 Share Repurchase/Acquisition Activities 2025-07-08 10:41
Celltrion USA announces U.S. launch of denosumab biosimilars, STOBOCLO® and OSENVELT® (denosumab-bmwo) 2025-07-08 10:08
SCG Cell Therapy Announces Clearance of Investigational New Drug Application by the China NMPA for SCG101V 2025-07-08 10:02
WuXi AppTec Receives MSCI ESG AAA Leader Rating 2025-07-07 20:08
Nuevocor Strengthens Board with Appointment of Thierry Abribat 2025-07-07 13:00
ESG | HitGen Releases Its Inaugural Sustainability Report 2025-07-04 19:00
Everest Medicines Showcases Breakthroughs in Proprietary AI-Powered mRNA Platform at 2025 R&D Day Held in Shanghai 2025-07-04 16:58
Kexing Biopharm Makes Its Debut at CPHI 2025, Followed by the 2025 International Pharmaceutical Cooperation High-End Forum, One of the Kexing Biopharm's Series of Globalization Activities in Shanghai 2025-07-04 16:26
Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China 2025-07-04 08:30
Fangzhou Tops China's App Store Chart for Healthcare Apps 2025-07-03 18:43
MOTE Therapeutics Taps MaryJane Rafii as Chief Investment & Business Officer to Drive Global Growth of RNA Delivery Platform 2025-07-03 18:07
Akeso's First Bispecific ADC (Trop2/Nectin4 ADC) Enters Clinical Trials, Strengthening Leadership in 'IO+ADC' 2.0 Strategy 2025-07-03 14:46
Dizal's ZEGFROVY® (sunvozertinib) Receives FDA Accelerated Approval as the Only Targeted Oral Treatment for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations 2025-07-03 08:08
1 30 31 32 33 34 484